Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bile Duct Neoplasms × tipifarnib × Clear all

Sponsor

Conditions

Leukemia, Myelomonocytic, Acute 3 Leukemia, Myeloid, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Erythroblastic, Acute 3 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Wilms Tumor 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pheochromocytoma 1 Osteosarcoma 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Medulloblastoma 1

Interventions

Gemcitabine 11 Capecitabine 8 Cisplatin 7 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Oxaliplatin 3 Erlotinib Hydrochloride 3 trametinib 2 regorafenib 2 Leucovorin 2 trifluridine tipiracil drug combination 1 tremelimumab 1 spartalizumab 1 seribantumab 1 olutasidenib 1 durvalumab 1 derazantinib 1 dehydroftorafur 1 cediranib 1 cabozantinib 1 Trifluridine 1 Trastuzumab 1 Therapeutics 1 Sutures 1 Surgical Instruments 1 Standard of Care 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡